(VIANEWS) – Krystal Biotech (KRYS), InterDigital (IDCC), Paysign (PAYS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Krystal Biotech (KRYS)
781.5% sales growth and 8.87% return on equity
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Earnings Per Share
As for profitability, Krystal Biotech has a trailing twelve months EPS of $2.18.
PE Ratio
Krystal Biotech has a trailing twelve months price to earnings ratio of 84.25. Meaning, the purchaser of the share is investing $84.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.87%.
Volume
Today’s last reported volume for Krystal Biotech is 94177 which is 75.21% below its average volume of 379974.
Yearly Top and Bottom Value
Krystal Biotech’s stock is valued at $183.67 at 16:22 EST, below its 52-week high of $191.78 and way above its 52-week low of $93.95.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 149.6% and a drop 73.8% for the next.
Moving Average
Krystal Biotech’s worth is way above its 50-day moving average of $165.50 and way above its 200-day moving average of $137.56.
2. InterDigital (IDCC)
24.3% sales growth and 30.28% return on equity
InterDigital, Inc. operates as a global research and development company with focus primarily on wireless, visual, and related technologies. It designs and develops technologies that enable connected in a range of communications and entertainment products and services. It licenses or intend to license its innovations to companies providing products and services, including wireless communications, consumer electronics, personal computer, and automotive, as well as cloud-based services, such as video streaming. It designs and develops a range of innovations for use in digital cellular and wireless products and networks, including 2G, 3G, 4G, 5G, and IEEE 802-related products and networks. The company also develops cellular technologies, such as technologies related to CDMA, TDMA, OFDM/OFDMA, and MIMO for use in 2G, 3G, 4G, and 5G wireless networks, as well as mobile terminal devices; and 3GPP technology portfolio in 5G, 5G, advanced and 6G, as well as technologies for automobiles, wearables, smart homes, drones, and other connected consumer electronic products. In addition, it provides video coding and transmission technologies; and engages in the research and development of artificial intelligence. Further, the company's patented technologies are used in various products that include smartphones, tablets, consumer electronics, and base stations; televisions, laptops, gaming consoles, set-top boxes, streaming devices, and connected automobiles. InterDigital, Inc. was incorporated in 1972 and is headquartered in Wilmington, Delaware.
Earnings Per Share
As for profitability, InterDigital has a trailing twelve months EPS of $6.92.
PE Ratio
InterDigital has a trailing twelve months price to earnings ratio of 16.99. Meaning, the purchaser of the share is investing $16.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.28%.
Moving Average
InterDigital’s value is higher than its 50-day moving average of $107.63 and way above its 200-day moving average of $99.46.
Sales Growth
InterDigital’s sales growth is negative 1.9% for the current quarter and 24.3% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jul 10, 2024, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 1.36%.
Yearly Top and Bottom Value
InterDigital’s stock is valued at $117.59 at 16:22 EST, under its 52-week high of $119.86 and way above its 52-week low of $74.65.
3. Paysign (PAYS)
17.8% sales growth and 33.35% return on equity
PaySign, Inc. provides prepaid card products and processing services under the PaySign brand for corporate, consumer, and government applications. It offers various services, such as transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through PaySign, a card processing platform. The company also develops prepaid card programs for corporate incentive and rewards, including consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance; and payroll or general purpose reloadable cards, as well as gift or incentive cards. In addition, it offers Per Diem, Corporate Expense, and Business Travel Cards that allows businesses, and non–profits and government agencies the ability to control employee spending while reducing administration costs by eliminating the need for traditional expense reports. Further, the company provides payment claims processing and other administrative services; pharmacy-based voucher and copay, and medical claims and debit-based affordability programs; PaySign Premier, a demand deposit account debit card; and payment solution for source plasma collection centers, as well as customer service center and PaySign Communications Suite services. Its principal target markets for processing services comprise prepaid card issuers, retail and private-label issuers, small third-party processors, and small and mid-size financial institutions in the United States and Mexico. The company was formerly known as 3PEA International, Inc. and changed its name to PaySign, Inc. in April 2019. PaySign, Inc. was incorporated in 1995 and is headquartered in Henderson, Nevada.
Earnings Per Share
As for profitability, Paysign has a trailing twelve months EPS of $0.13.
PE Ratio
Paysign has a trailing twelve months price to earnings ratio of 33.15. Meaning, the purchaser of the share is investing $33.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.35%.
Sales Growth
Paysign’s sales growth is 26.8% for the present quarter and 17.8% for the next.
Volume
Today’s last reported volume for Paysign is 606726 which is 141.12% above its average volume of 251622.
4. The Simply Good Foods Company (SMPL)
9.7% sales growth and 8.97% return on equity
The Simply Good Foods Company operates as a consumer packaged food and beverage company in North America and internationally. The company develops, markets, and sells snacks and meal replacements. It offers primarily nutrition bars, ready-to-drink (RTD) shakes, sweet and salty snacks, protein bars, cookies, pizza, protein chips, recipes, and confectionery products, as well as licensed frozen meals under the Atkins, Atkins Endulge, and Quest brand names. The company distributes its products to various retail channels, such as mass merchandise, grocery and drug channels, club stores, convenience stores, gas stations, and other channels. It also sells its products through e-commerce channels, including atkins.com, questnutrition.com, and amazon.com. The Simply Good Foods Company is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, The Simply Good Foods Company has a trailing twelve months EPS of $1.39.
PE Ratio
The Simply Good Foods Company has a trailing twelve months price to earnings ratio of 26.58. Meaning, the purchaser of the share is investing $26.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.97%.
Yearly Top and Bottom Value
The Simply Good Foods Company’s stock is valued at $36.94 at 16:22 EST, way below its 52-week high of $43.00 and way above its 52-week low of $30.00.
Sales Growth
The Simply Good Foods Company’s sales growth for the next quarter is 9.7%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.3%, now sitting on 1.27B for the twelve trailing months.
5. Grifols, S.A. (GRFS)
8.1% sales growth and 3.48% return on equity
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuum–from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring–to serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.
Earnings Per Share
As for profitability, Grifols, S.A. has a trailing twelve months EPS of $0.1.
PE Ratio
Grifols, S.A. has a trailing twelve months price to earnings ratio of 70. Meaning, the purchaser of the share is investing $70 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.48%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 53.3% and 100%, respectively.
Volume
Today’s last reported volume for Grifols, S.A. is 1343890 which is 10.42% above its average volume of 1217000.
6. Brinks Company (BCO)
6% sales growth and 23.33% return on equity
The Brink's Company provides secure transportation, cash management, and other security-related services in North America, Latin America, Europe, and internationally. The company offers armored vehicle transportation of valuables; automated teller machine (ATM) management services, such as cash replenishment, replenishment forecasting, cash optimization, ATM remote monitoring, service call dispatching, transaction processing, installation, and first and second line maintenance services; network infrastructure; and cash-in-transit services. It also provides transportation services for diamonds, jewelry, precious metals, securities, bank notes, currency, high-tech devices, electronics, and pharmaceuticals; vault outsourcing and money processing services; and services related to deploying and servicing intelligent safes and safe control devices, as well as cashier balancing, counterfeit detection, account consolidation, electronic reporting, check imaging, and reconciliation services. In addition, the company offers technology applications, including online cash tracking, cash inventory management, and other web-based tools. Further, it provides bill payment acceptance and processing services; prepaid cards and corporate debit cards; and security system design and installation services that include alarms, motion detectors, closed-circuit televisions, and digital video recorders, as well as access control systems comprising card and biometric readers, electronic locks, and turnstiles. Additionally, the company offers monitoring services; and security and guarding services to protect airports, offices, warehouses, stores, and public venues. It serves banks and financial institutions, retailers, government agencies, mints, jewelers, and other commercial operations. The company was formerly known as The Pittston Company and changed its name to The Brink's Company in May 2003. The Brink's Company was founded in 1859 and is headquartered in Richmond, Virginia.
Earnings Per Share
As for profitability, Brinks Company has a trailing twelve months EPS of $2.62.
PE Ratio
Brinks Company has a trailing twelve months price to earnings ratio of 38.47. Meaning, the purchaser of the share is investing $38.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.33%.
Volume
Today’s last reported volume for Brinks Company is 232201 which is 10.19% below its average volume of 258570.
Sales Growth
Brinks Company’s sales growth is 3.6% for the present quarter and 6% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 10, 2024, the estimated forward annual dividend rate is 0.97 and the estimated forward annual dividend yield is 0.95%.
7. Covenant Logistics Group (CVLG)
5.6% sales growth and 10.78% return on equity
Covenant Logistics Group, Inc., together with its subsidiaries, provides transportation and logistics services in the United States. It operates through four segments: Expedited, Dedicated, Managed Freight, and Warehousing. The Expedited segment primarily provides truckload services with high service freight and delivery standards, such as 1,000 miles in 22 hours or 15-minute delivery windows. The Dedicated segment provides customers with committed truckload capacity over contracted periods using equipment either owned or leased by the company. The Managed Freight segment offers brokerage services, including logistics capacity by outsourcing the carriage of customers' freight to third parties; and transport management services, such as logistics services on a contractual basis to customers who prefer to outsource their logistics needs. The Warehousing segment provides day-to-day warehouse management services to customers. This segment also provides shuttle and switching services to shuttling containers and trailers. The company also engages in used equipment sales and leasing business. It serves transportation companies, such as parcel freight forwarders, less-than-truckload carriers, and third-party logistics providers; and traditional truckload customers, including manufacturers, retailers, and food and beverage shippers. The company was formerly known as Covenant Transportation Group, Inc. and changed its name to Covenant Logistics Group, Inc. in July 2020. Covenant Logistics Group, Inc. was founded in 1986 and is based in Chattanooga, Tennessee.
Earnings Per Share
As for profitability, Covenant Logistics Group has a trailing twelve months EPS of $3.04.
PE Ratio
Covenant Logistics Group has a trailing twelve months price to earnings ratio of 15.99. Meaning, the purchaser of the share is investing $15.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.78%.
Yearly Top and Bottom Value
Covenant Logistics Group’s stock is valued at $48.61 at 16:22 EST, way under its 52-week high of $57.57 and way above its 52-week low of $38.25.
